clopidogrel has been researched along with Acute Kidney Failure in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (83.33) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Hatakeyama, Y; Horino, T; Matsumoto, T; Okuhara, Y; Terada, Y | 1 |
Badia, T; Bellandi, F; Leoncini, M; Maioli, M; Toso, A; Tropeano, F; Villani, S | 1 |
Goligorsky, MS; Hohenstein, B; Hugo, CP; Lerea, KM; Nieswandt, B; Schwarzenberger, C; Sradnick, J | 1 |
Abe, Y; Hamauchi, A; Ito, K; Miyake, K; Nakashima, H; Sasatomi, Y; Tada, K; Takahashi, K; Uchida, A; Watanabe, R; Yasuno, T | 1 |
Douglass-Molloy, H; Hennessey, DB; Jack, G; Kinnear, N | 1 |
Anker, SD; Ponikowski, P; Ronco, C | 1 |
1 trial(s) available for clopidogrel and Acute Kidney Failure
Article | Year |
---|---|
Early high-dose rosuvastatin and cardioprotection in the protective effect of rosuvastatin and antiplatelet therapy on contrast-induced acute kidney injury and myocardial damage in patients with acute coronary syndrome (PRATO-ACS) study.
Topics: Acute Coronary Syndrome; Acute Kidney Injury; Cardiotonic Agents; Clopidogrel; Contrast Media; Coronary Angiography; Creatine Kinase, MB Form; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myocardium; Necrosis; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Ticlopidine; Treatment Outcome; Troponin I | 2014 |
5 other study(ies) available for clopidogrel and Acute Kidney Failure
Article | Year |
---|---|
Long-term continuous use of proton-pump inhibitors is associated with renal function decline in patients without acute kidney injury.
Topics: Acute Kidney Injury; Aged; Angiotensin Receptor Antagonists; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clopidogrel; Diabetes Mellitus; Female; Gastroesophageal Reflux; Glomerular Filtration Rate; Histamine H2 Antagonists; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Kidney; Male; Middle Aged; Peptic Ulcer; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Retrospective Studies; Steroids; Time Factors | 2021 |
Platelets are relevant mediators of renal injury induced by primary endothelial lesions.
Topics: Acute Kidney Injury; Animals; Blood Platelets; Cell-Derived Microparticles; Clopidogrel; Disease Models, Animal; Endothelial Cells; Endothelium, Vascular; Male; Mice, Inbred C57BL; P-Selectin; Platelet Activation; Ticlopidine | 2015 |
Clopidogrel-induced Thrombotic Microangiopathy in a Patient with Hypocomplementemia.
Topics: Acute Kidney Injury; Adrenal Cortex Hormones; Aged; Anemia, Hemolytic; Cerebral Infarction; Clopidogrel; Humans; Male; Plasma Exchange; Platelet Aggregation Inhibitors; Thrombotic Microangiopathies; Ticlopidine | 2016 |
Life-threatening Wunderlich's syndrome with concurrent clopidogrel use.
Topics: Acute Kidney Injury; Blood Transfusion; Clopidogrel; Embolization, Therapeutic; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Syndrome; Ticlopidine | 2016 |
Cardiorenal syndromes--recommendations from clinical practice guidelines: the cardiologist's view.
Topics: Acute Disease; Acute Kidney Injury; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Chronic Disease; Clopidogrel; Heart Failure; Humans; Kidney Failure, Chronic; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Renal Insufficiency; Shock, Cardiogenic; Stroke Volume; Syndrome; Ticlopidine | 2010 |